enGenome is hosting Federica De Paoli at the 10th HUGO Variant Effect Prediction Training Course at VEPTC 2026 in Athens
Public source
Publisher name
Public post
We're happy to see Federica De Paoli take the stage at VEPTC 2026 (10th HUGO Variant Effect Prediction Training Course) this month in Athens 🎤 She'll be unpacking how A…
Company
enGenome
Genomic Variant Interpretation to the Next Level!
- Industry
- Software Development
- Location
- Pavia, IT
- Company size
- 11–50 employees
About enGenome
enGenome provides the expertise and software technologies for the analysis and the interpretation of molecular data in order to support translational research and clinical practice. Our bioinformatics products and services aim to improve the diagnosis of genetic diseases and patients therapies by producing accurate genetic reports with actionable results.
See moreLatest activity
Latest activity from enGenome
3 signals
Research & Knowledge
enGenome highlights eVai's Suggested Diagnosis feature using machine learning to bring together variant pathogenicity, phenotypic similarity, inheritance fit, and variant quality data.
Research & Knowledge
enGenome highlights that eVai has been cited in 55 scientific publications reflecting its growing use by researchers and clinical teams across a wide range of rare diseases and genetic conditions.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
BostonGene
BostonGene is heading to Houston for SOHO2026 to present two abstracts showcasing novel genomic classifier and immunotherapy selection frameworks designed to extract actionable insights from complex multimodal datasets.
Presence & Recognition
SCC Soft Computer
SCC Soft Computer is exhibiting at Genomics Connect: The NHS Genomics & Clinical Integration Conference
Presence & Recognition
Sano Centre for Computational Medicine
Sano Centre for Computational Medicine's Structural and Functional Genomics Group attended and represented at ECCB 2026 in Geneva.
Presence & Recognition
GenomOncology
GenomOncology panelist Ariel Schwartz will contribute to a panel discussion hosted by the Cleveland Women in Biotech focused on AI in Biotech and Healthcare at Cleveland Tech Week on September 30th.
Presence & Recognition
Eye2Gene